Berlin, Germany — The annual European Society for Medical Oncology (ESMO) Congress, held from October 17–21, became a stage for China’s rapid ascent in pharmaceutical innovation. This year, Chinese biotech companies achieved record participation, with 35 studies accepted for ...Learn More

China’s innovative drug sector has notched another record-breaking milestone as Innovent Biologics announced a partnership worth up to $11.4 billion with Takeda Pharmaceutical.According to the agreement, Innovent will receive a $1.2 billion upfront payment, including a $100 ...Learn More